• Issue

    Hepatology Research: Volume 51, Issue 9

    919-1006
    September 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 919-920
  • First Published: September 2021

EDITORIAL

Available weapons in our arsenal for de novo antibody-mediated rejection following liver transplantation—Fighting an invisible foe

Susumu Eguchi, 
  • Pages: 921-922
  • First Published: September 2021

VIRAL HEPATITIS

Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment-naïve patients with chronic hepatitis B following entecavir therapy

Joonho Jeong,  Jung Woo Shin,  Seok Won Jung,  Seung Bum Lee,  Eun Ji Park,  Neung Hwa Park, 
  • Pages: 923-932
  • First Published: 05 July 2021

aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C

Yuki Yamashita,  Satoru Joshita,  Ayumi Sugiura,  Tomoo Yamazaki,  Hiroyuki Kobayashi,  Shun-ichi Wakabayashi,  Yosuke Yamada,  Soichiro Shibata,  Hideo Kunimoto,  Takanobu Iwadare,  Makiko Matsumura,  Chiharu Miyabayashi,  Taiki Okumura,  Sachie Ozawa,  Yuichi Nozawa,  Natsuko Kobayashi,  Michiharu Komatsu,  Naoyuki Fujimori,  Hiromi Saito,  Takeji Umemura, 
  • Pages: 933-942
  • First Published: 03 July 2021

STEATOHEPATITIS

Open Access

Efficacy and safety of apararenone (MT-3995) in patients with nonalcoholic steatohepatitis: A randomized controlled study

Takeshi Okanoue,  Michiie Sakamoto,  Kenichi Harada,  Masaya Inagaki,  Naoko Totsuka,  Gaia Hashimoto,  Hiromitsu Kumada, 
  • Pages: 943-956
  • First Published: 14 July 2021

CIRRHOSIS

Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan

Hiroki Nishikawa,  Makoto Shiraki,  Akira Hiramatsu,  Nagisa Hara,  Kyoji Moriya,  Keisuke Hino,  Kazuhiko Koike, 
  • Pages: 957-967
  • First Published: 31 May 2021

Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology

Nahoko Kikuchi,  Haruki Uojima,  Hisashi Hidaka,  Shuichiro Iwasaki,  Naohisa Wada,  Kousuke Kubota,  Takahide Nakazawa,  Akitaka Shibuya,  Tomoaki Fujikawa,  Makoto Kako,  Teruko Sato,  Wasaburo Koizumi, 
  • Pages: 968-978
  • First Published: 16 July 2021

HEPATOCELLULAR CARCINOMA AND OTHER MALIGNACY

Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria

Takuya Sho,  Goki Suda,  Koji Ogawa,  Megumi Kimura,  Akinori Kubo,  Yoshimasa Tokuchi,  Takashi Kitagataya,  Osamu Maehara,  Shunsuke Ohnishi,  Taku Shigesawa,  Akihisa Nakamura,  Ren Yamada,  Masatsugu Ohara,  Naoki Kawagishi,  Mitsuteru Natsuizaka,  Masato Nakai,  Kenichi Morikawa,  Ken Furuya,  Masaru Baba,  Yoshiya Yamamoto,  Kazuharu Suzuki,  Takaaki Izumi,  Takashi Meguro,  Katsumi Terashita,  Jun Ito,  Takuto Miyagishima,  Naoya Sakamoto, 
  • Pages: 979-989
  • First Published: 10 July 2021

SURGERY

The efficacy of rituximab treatment for antibody-mediated rejection in liver transplantation: A retrospective Japanese nationwide study

Seisuke Sakamoto,  Nobuhisa Akamatsu,  Kiyoshi Hasegawa,  Hideki Ohdan,  Ken Nakagawa,  Hiroto Egawa, 
  • Pages: 990-999
  • First Published: 05 April 2021

SHORT COMMUNICATION

Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases

Reiichiro Kondo,  Nao Kawaguchi,  Matthew J. McConnell,  Aurelio Sonzogni,  Lisa Licini,  Clarissa Valle,  Pietro A. Bonaffini,  Sandro Sironi,  Maria Grazia Alessio,  Giulia Previtali,  Michela Seghezzi,  Xuchen Zhang,  Zhaoli Sun,  Teruo Utsumi,  Mario Strazzabosco,  Yasuko Iwakiri, 
  • Pages: 1000-1006
  • First Published: 14 July 2021